Human renal‐cell carcinoma cells are able to activate natural killer cells
- 8 May 1992
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 51 (2), 290-295
- https://doi.org/10.1002/ijc.2910510219
Abstract
We previously reported that natural killer (NK) cells that had infiltrated renal‐cell carcinoma (RCC) proliferated vigorously in culture with interleukin‐2 (IL‐2) and lysed autologous tumor cells. In this study, we investigate the susceptibility of RCC cells to NK‐cell lysis and their ability to stimulate proliferation and increase phenotypic expression and function of NK cells. Cells from primary culture of RCC (p‐RCC cells) were significantly more susceptible to the lysis mediated by human NK3.3 clones than were cells from primary culture of metastatic melanomas. Both RCC‐cell clones and cells from primary culture of non‐tumorous kidneys were also susceptible to lysis by NK3.3 clones and IL‐2‐activated peripheral blood lymphocytes (PBLs). Incubation of NK3.3 clones with p‐RCC cells in the absence of IL‐2 induced proliferation of NK3.3 clones, whereas incubation with cells from primary culture of metastatic melanomas, K562 cells, or any others tested did not. The p‐RCC cells from earlier passages were more potent inducers of NK‐cell proliferation than were those from older passages. Cell‐free culture superna‐tants of p‐RCC cells with or without NK3.3 clones failed to induce NK‐cell proliferation. Incubation of CD16+ NK cells purified from PBLs with p‐RCC cells induced higher proliferation of the NK cells only in the presence of IL‐2, whereas incubation with cells from primary culture of metastatic melanomas did not. Incubation of NK3.3 clones with p‐RCC cells resulted in an increase in CD16, CD25 (IL‐2 receptor‐α), and HLA‐DR antigen expression and cytotoxicity in NK3.3 clones. In summary, these results suggest that RCC cells are able to activate NK cells, potentially through cell‐to‐cell interaction.This publication has 23 references indexed in Scilit:
- Study of Tumor-Infiltrating Lymphocytes for Adoptive Therapy of Renal Cell Carcinoma (RCC) and Metastatic Melanoma: Sequential Proliferation of Cytotoxic Natural Killer and Noncytotoxic T Cells in RCCJournal of Immunotherapy, 1991
- Til from renal‐cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activityInternational Journal of Cancer, 1990
- Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.The Journal of Experimental Medicine, 1989
- Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.The Journal of Experimental Medicine, 1988
- Renal cell cultureJournal of Electron Microscopy Technique, 1988
- Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cellsCarcinogenesis: Integrative Cancer Research, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562.The Journal of Experimental Medicine, 1985
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Ultrastructure of the Clear Cells in Renal Carcinomas and its Importance for the Demonstration of their Renal OriginNature, 1960